Keyphrases
Poly(D,L-lactic-co-glycolic acid)
100%
Novel Adjuvant
100%
Quality by Design
100%
Lipid-polymer Hybrid Nanoparticles
100%
Trehalose 6,6'-dibehenate
75%
Dimethyldioctadecylammonium
75%
Hybrid Nanoparticles
50%
Polyvinyl Alcohol
50%
Optimal Operating
50%
Polydispersity Index
50%
Zeta Potential
50%
Critical Process Parameters
50%
Operating Space
50%
Size-polydispersity
50%
Nanoparticles
50%
Phase Transition
25%
Total Solids
25%
Structural Effect
25%
Lipids
25%
Bromide
25%
Phase Stability
25%
Critical Quality Attributes
25%
Particle Size
25%
Solidity Ratio
25%
Nanoparticle Adjuvant
25%
Hybrid Matrix
25%
Nanoshell
25%
Acetone Concentration
25%
Cellular Immunity
25%
Adjuvant Properties
25%
Oilfield Produced Water
25%
Th17 Immune Response
25%
Chlamydia Trachomatis
25%
Total Concentration
25%
Intracellular Bacteria
25%
Thermotropic Phase Behavior
25%
Lipid Bilayer
25%
Optimal Formulation
25%
Th17 Response
25%
Humoral Immunity
25%
Immunopotentiator
25%
Mucosal Vaccine
25%
Hybrid Lipid-polymer Nanoparticles
25%
CAF01
25%
Formulation Design
25%
Multiple Linear Regression Analysis
25%
Membrane Structure
25%
Water Phase
25%
Cationic Surfactant
25%
Stabilizer
25%
Face-centered Central Composite Design
25%
Mycobacterium Tuberculosis (M. tb)
25%
Liposomes
25%
Lipid Membrane
25%
Cryogenic Electron Microscopy
25%
Single Emulsion
25%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Adjuvant
100%
Glycolic Acid
66%
Trehalose
50%
Zeta Potential
33%
Polyvinyl Alcohol
33%
Cryo-Transmission Electron Microscopy
16%
Intracellular Bacterium
16%
Liposome
16%
Mycobacterium Tuberculosis
16%
Diseases
16%
Chlamydia Trachomatis
16%
Formulation Design
16%
Cationic Surfactant
16%
Membrane Lipid
16%
Dimethyldioctadecylammonium Bromide
16%
Material Science
Nanoparticle
100%
Cationic Surfactant
20%
Composite Material
20%
Stabilizer (Agent)
20%
Cryo-Transmission Electron Microscopy
20%
Lipid Bilayer
20%
Membrane Structure
20%
Polymer Nanoparticles
20%